City of Hope, Beckman Research Institute

Total Awards: 
Award Value: 
Institution type: 
Not for profit
Short Name: 

Awards to the Institution

Program Investigator Award Title Award Value
Basic Biology III Jiing-Kuan Yee Use of human iPS cells to study spinal muscular atrophy $1,268,868
Conference Fouad Kandeel 2013 Rachmiel Diabetes and Obesity Levine Symposium - Advances in Diabetes Research $27,750
Clinical Trial Stage Projects Joseph Rosenthal Treatment of sickle cell disease by induction of mixed chimerism and immune tolerance using CD4+ T-depleted haploidentical blood stem cell transplant $5,742,180
Early Translational II David DiGiusto Development of RNA-based approaches to stem cell gene therapy for HIV $3,097,160
Alpha Stem Cell Clinics John Zaia The Innovation-Alpha Clinic for Cellular Therapies (I-ACT) – A Program for the Development and Delivery of Innovative Cell-based Treatments and Cures for Life-threatening Diseases. $8,000,000
Conference - Manage The SPARK Annual Meeting Paul Salvaterra Manage the 2017 SPARK Annual Meeting $22,555
Research Training II Michael Barish City of Hope Research Training Program in Stem Cell Biology $2,197,782
Conference Fouad Kandeel 2011 Rachmiel Levine Diabetes and Obesity Symposium: Advances in Diabetes Research $15,000
Late Stage Preclinical Projects John Zaia Ex Vivo Gene Engineering of Blood Stem Cells for Enhanced Chemotherapy Efficacy in Glioblastoma Patients $3,684,259
Disease Team Research I Karen Aboody Stem Cell-mediated Therapy for High-grade Glioma: Toward Phase I-II Clinical Trials $17,890,623
Tools and Technologies III Joseph Gold Development of a scalable, practical, and transferable GMP-compliant suspension culture-based differentiation process for cardiomyocyte production from human embryonic stem cells. $891,518
Conference - The 2017 Alpha Stem Cell Clinic Annual Symposium John Zaia 2nd Annual Symposium of the CIRM Alpha Stem Cell Clinics Network "Alpha Clinics - Making the Future a Reality for Stem Cell-Based Therapies" $79,287
Early Translational III Stephen Forman Targeting glioma cancer stem cells with receptor-engineered self-renewing memory T cells $5,215,447
Conference Fouad Kandeel 2012 Rachmiel Levine Diabetes and Obesity Symposium: Advances in Diabetes Research $15,000
Quest - Discovery Stage Research Projects Saul Priceman Chimeric Antigen Receptor-Engineered Stem/Memory T Cells for the Treatment of Recurrent Ovarian Cancer $1,381,104
SPARK Paul Salvaterra SPARK Award Program in Stem Cell Biology for California High School Students $309,576
Quest - Discovery Stage Research Projects Markus Müschen Lgr5-mediated self-renewal in B cell selection and leukemia-initiation $2,186,520
Basic Biology IV Yanhong Shi Modeling Alexander disease using patient-specific induced pluripotent stem cells $1,366,656
Conference Richard Jove New Approaches in Cell Based Therapies $20,000
Late Stage Preclinical Projects Xiuli Wang CMV-specific T cells expressing anti-HIV CAR and CMV vaccine boost as immunotherapy for HIV/AIDS $3,812,797
SEED Grant Timothy O'Connor Sources of Genetic Instability in Human Embryonic Stem Cells. $327,311
Therapeutic Translational Research Projects Yanhong Shi Process development for establishing an iPSC-based therapeutic candidate for Canavan disease $7,377,384
Quest - Discovery Stage Research Projects Yuan Chen A Novel Approach to Eradicate Cancer Stem Cells $1,839,484
Creativity Awards Paul Salvaterra Creativity Award Program in Stem Cell Biology for California High School Students $260,825
Conference Richard Jove Innovation and Translational Stem Cell Therapy for Diabetes and Neurological Diseases: Paving the way for real life solutions $14,878
Tools and Technologies I Larry Couture Development of Suspension Adaptation, Scale-up cGMP Banking and Cell Characterization Technologies for hESC Lines $882,929
Conference II Fouad Kandeel 2016 Rachmiel Levine-Arthur Riggs Diabetes Research Symposium $10,000
Clinical Trial Stage Projects Christine Brown Phase I Study of Chimeric Antigen Receptor Engineered Central Memory T cells for the Treatment of Malignant Glioma $12,753,854
Disease Team Planning Michael Barish Genetically-modified neural stem cells for treatment of high-grade glioma $55,000
Conference Richard Jove Innovative Partnerships: Bringing Stem Cell Discoveries to the Clinic $14,994
New Faculty I Tiziano Barberi Skeletal muscle development from hESC and its in vivo applications in animal models of muscular dystrophy $131,840
Conference Fouad Kandeel 2009 Rachmiel Levine Diabetes and Obesity Symposium: Advances in Diabetes Biology, Immunology and Cell Therapy $15,000
Quest - Discovery Stage Research Projects Saswati Chatterjee Genome Editing of Sinusoidal Endothelial Stem Cells for Permanent Correction of Hemophilia A $2,182,193
Early Translational II Yanhong Shi Developing a therapeutic candidate for Canavan disease using induced pluripotent stem cell $1,835,983
Strategic Partnership III Track A John Zaia A Phase I, Open-Label Study To Assess The Safety, Feasibility and Engraftment of Zinc Finger Nucleases (ZFN) CCR5 Modified Autologous CD34+ Hematopoietic Stem/Progenitor Cells (SB-728MR-HSPC) with Escalating Doses of Busulfan In HIV-1 (R5) Infected Sub... $5,583,438
Conference Fouad Kandeel 15th Annual Rachmiel Levine Diabetes and Obesity Symposium $20,000
Icon for xls export